Cancer Detection Suppliers Serving Libya

GE HealthCare operates as a leader in precision care, integrating advanced technologies with patient-focused solutions to enhance healthcare delivery. The company invests approximately $1 billion annually in research and development, focusing on ...

We are a globally orientated German company with innovative products in the sector of point-of-care diagnostics and telemedical solutions that are used in clinics, practices and in everyone’s everyday life. Preventis GmbH was founded 2003 in ...

At Twist Bioscience, we work in the service of customers who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals, and data storage, by using our synthetic DNA tools, our customers are developing ways ...

Guided Therapeutics, Inc. (OTC: QB GTHP) is committed to developing groundbreaking medical devices using our patented biophotonic technology to detect diseases earlier, more accurately, and more efficiently than other tests. Since Guided ...

Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses ...

CureMetrix is committed to the advancement of technology that will improve cancer survival rates worldwide. Our research is focused on leveraging artificial intelligence and deep learning to develop the next generation of medical image analysis ...

Hybribio, a leader in molecular diagnostic products in China, is engaged in the nucleic acid diagnostic field. It provides a full operation chain from research and development to production and sales. The company's capabilities are enriched by an ...

We are developing blood tests that detect cancer in its earliest stages so we can transform cancer into a disease that’s preventable and curable. We are developing Signal-X™, a multi-cancer platform able to detect various types of high-burden ...

Getting ahead of cancer is crucial no matter where people are in their cancer journey. From earlier cancer detection to treatment guidance and monitoring, we are helping people get the answers they need to make more informed decisions across the ...

Rapid Biosensor is a Cambridge-based technology and business development company exploiting technology for rapid screening of infectious diseases. Our first product is a 'Breathalyser' style device for screening TB in a few minutes at the ...

BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. Our technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the ...

Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...

Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...

In late 1999, out of an urge to innovate and excel, John Bottjer, Nizar Mullani, and Thorsten Trotzenberg founded 3Gen as a cutting-edge product design and development company situated in beautiful Orange County, California. At the 2001 meeting of ...

At Bionano Genomic, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. Our team is not afraid to venture ...

ScreenPoint Medical was founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady, world leading experts in quantitative breast image analysis and computer aided detection. They have led research projects in the field for over ...

Lightpoint Medical is a technology leader in targeted cancer surgery. We are developing miniaturized imaging and sensing tools for more precise intra-operative cancer detection. Our mission is to improve the lives of people with cancer by ...

FONAR was incorporated in 1978, making it the first, oldest and most experienced MR manufacturer in the industry. FONAR introduced the world's first commercial MRI (a whole-body MRI scanner) in 1980, and went public in 1981. In 1982, FONAR ...

Stilla Technologies is the multiplex digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer and liquid biopsy studies, cell and gene therapies, ...

TransLite LLC is a small high tech company comprising dedicated people who design, manufacture and sell medical devices that can help reduce the pain and trauma to patients during venous access and treatment of varicose veins. Over 70,000 medical ...